Connect with us

Business

Why More UK Homeowners Are Upgrading Their Door Locks in 2026

Published

on

Why More UK Homeowners Are Upgrading Their Door Locks in 2026

Home security has become a growing concern for UK households, and in 2026, many homeowners are taking a closer look at something that’s often overlooked: their door locks.

While alarms, cameras and lighting tend to dominate conversations around home security, experts are increasingly pointing to door locks as one of the most important — and vulnerable — parts of a property’s defenses. As burglary methods evolve and older hardware struggles to keep up, upgrading door locks is quickly becoming a priority rather than an afterthought.

Changing Burglary Tactics Are Driving Lock Upgrades

Modern burglaries rarely resemble the dramatic break-ins portrayed in films. In reality, most intrusions are quick, targeted, and focused on exploiting weak points around doors and entry systems.

Older locks, particularly those fitted more than a decade ago, were not designed to withstand today’s most common attack methods. Techniques such as snapping, drilling, bumping and lock manipulation have become more widely understood, leaving outdated hardware exposed.

As awareness of these risks has grown, homeowners are realising that upgrading door locks can significantly reduce the likelihood of forced entry — often without the need for major renovations or expensive security systems.

Advertisement

Insurance and Security Standards Are Playing a Bigger Role

Another factor driving lock upgrades is insurance compliance. Many insurers now expect homes to meet minimum security standards, particularly for external doors on uPVC and composite properties.

Locks that fail to meet recognised security ratings may not only increase the risk of burglary but could also complicate insurance claims following a break-in. This has prompted more homeowners to seek out locks that are tested, certified and designed to resist common attack methods.

Rather than reacting after a burglary has occurred, many are choosing to upgrade proactively, ensuring their door locks meet modern expectations for both security and peace of mind.

Why Door Locks Are the Foundation of Home Security

While alarms and cameras can alert homeowners to a problem, door locks are the first line of defence. A strong locking system can prevent an intruder from gaining access in the first place, making other security measures far more effective.

Advertisement

High-quality locks are designed to work in harmony with the door itself, providing resistance against forced entry while maintaining smooth everyday use. When locks are worn, outdated or poorly installed, even the most robust doors can become vulnerable.

This has led to growing interest in modern locking solutions that offer improved strength, durability and compatibility with today’s door systems.

The Shift Towards High-Security Locking Solutions

One of the most noticeable trends in 2026 is the move towards high-security door locks that are specifically engineered to counter modern attack techniques.

These locks often feature reinforced materials, anti-snap protection, and advanced internal mechanisms that make them significantly harder to compromise. For many homeowners, upgrading to modern lock designs provides a cost-effective way to improve security without altering the appearance of their property.

Advertisement

You can see examples of modern high-security door locks and how they’re being used in UK homes by exploring specialist retailers that focus on security-rated locking solutions rather than generic hardware.

A Practical Upgrade With Long-Term Benefits

Unlike some home improvements, upgrading door locks offers immediate and lasting benefits. Improved security is the obvious advantage, but homeowners also report smoother operation, reduced wear on door mechanisms, and greater confidence when leaving their property unattended.

For rental properties and shared homes, upgraded locks can also help landlords meet safety expectations while reducing the risk of repeated break-ins — a growing concern in urban areas.

As security awareness continues to rise, it’s clear that door locks are no longer being treated as a background detail. Instead, they’re becoming a central part of how homeowners protect their properties.

Advertisement

Looking Ahead

With crime prevention advice, insurance requirements and consumer awareness all pointing in the same direction, it’s no surprise that more UK homeowners are choosing to upgrade their door locks in 2026.

Rather than waiting for something to go wrong, many are taking a proactive approach — strengthening their homes from the outside in and ensuring their first line of defence is up to modern standards.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Hershey introduces Dot’s original snack mix

Published

on

Hershey introduces Dot’s original snack mix

Features a blend of Dot’s Original snack pieces.

Continue Reading

Business

Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Medtronic plc (MDT) Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDT

Company Participants

Thierry Pieton – Executive VP & CFO

Conference Call Participants

Advertisement

Michael Kratky – Leerink Partners LLC, Research Division

Presentation

Michael Kratky
Leerink Partners LLC, Research Division

Advertisement

All right. I think we can kick things off. But thank you all for joining. My name is Mike Kratky. I’m our Senior MedTech Analyst at Leerink and thrilled to be joined today by Medtronic’s CFO, Thierry Pieton. So thanks so much for joining.

Thierry Pieton
Executive VP & CFO

Yes. Thanks for having me.

Advertisement

Question-and-Answer Session

Michael Kratky
Leerink Partners LLC, Research Division

Advertisement

You just passed the 1-year mark at Medtronic. We’d love to maybe kick it off by hearing from your perspective, how the business has evolved over the last year. And as you look out over the next 12 months, what gets you most excited?

Thierry Pieton
Executive VP & CFO

Yes. Look, first of all, it’s been an interesting 12 months. I mean we’ve had a lot of things going on between sort of accelerating some of the new product launches and some of the portfolio actions that we’ve taken that I’m sure we’ll talk about, the IPO of MiniMed and we’re going back on offense in M&A, and we’ve done a couple of things in the last 3 or 4 months. So it’s been pretty busy. Look, I think the business has growing confidence.

Advertisement

I think a lot of the work that has been done for several years in the past few years to build the portfolio and to reinforce some of the operating mechanisms in the team and to work on R&D on some of the innovations that we’re launching now, it’s starting to pay off. And I think there’s a lot of excitement

Advertisement
Continue Reading

Business

More support as heating oil costs 'double'

Published

on

More support as heating oil costs 'double'

Rural farmers and homeowners are struggling to afford heating oil as prices rise.

Continue Reading

Business

Outlook For Global Economy As Middle East Conflict Creates A Critical 'Chokepoint'

Published

on

Outlook For Global Economy As Middle East Conflict Creates A Critical 'Chokepoint'

Outlook For Global Economy As Middle East Conflict Creates A Critical 'Chokepoint'

Continue Reading

Business

Paro expands South Asian-inspired portfolio

Published

on

Paro expands South Asian-inspired portfolio

Company adds lentil crisps to expand its lentil-focused product line. 

Continue Reading

Business

Apura Ingredients, New Tree Fruit Co. form partnership

Published

on

Apura Ingredients, New Tree Fruit Co. form partnership

Partnership integrating NewTree’s “de-sugared” fruit technology into Apura’s portfolio. 

Continue Reading

Business

Rambus SVP, general counsel Shinn sells $404k in stock

Published

on


Rambus SVP, general counsel Shinn sells $404k in stock

Continue Reading

Business

Geox FY2025 presentation: net loss halved despite 8% sales decline

Published

on

Geox FY2025 presentation: net loss halved despite 8% sales decline


Geox FY2025 presentation: net loss halved despite 8% sales decline

Continue Reading

Business

Total Energy Services Inc. (TOT:CA) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Conference Call Participants

Josef Schachter – Schachter Energy Research Services Inc.
Tim Monachello – ATB Cormark Capital Markets Inc., Research Division

Presentation

Advertisement

Operator

Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome you to the Total Energy Services Fourth Quarter and Full Year 2025 Results Conference Call. [Operator Instructions] Thank you.

I would now like to turn the conference over to Mr. Daniel Halyk, President and Chief Executive Officer. Please go ahead.

Advertisement

Daniel Halyk
President, CEO & Director

Thank you, Krista. Good morning, and welcome to Total Energy Services Fourth Quarter 2025 Conference Call. Present with me is Yuliya Gorbach, Total’s VP, Finance and CFO. We will review with you Total’s financial and operating highlights for the 3 months ended December 31, 2025, and then provide an outlook for our business and open up the phone lines for questions. Yuliya, please go ahead.

Yulia Gorbach
VP of Finance & CFO

Advertisement

Thank you, Dan. During the course of this conference call, information may be provided containing forward-looking information concerning Total’s projected operating results, anticipated capital expenditure trends and projected activity in the oil and gas field industry. Actual events or results may differ materially from those reflected in Total’s forward-looking statements due to a number of risks, uncertainties and other factors affecting Total’s businesses and the oil and gas service industry in general. These risks, uncertainties and other factors are described under the heading Risk Factors and elsewhere in Total’s most recently filed annual information form and other documents filed with Canadian provincial securities authorities that are available

Advertisement
Continue Reading

Business

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (XERS) Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:30 AM EDT

Company Participants

John Shannon – CEO & Director
Steven Pieper – Chief Financial Officer

Conference Call Participants

Advertisement

Jenna Davidner – Barclays Bank PLC, Research Division

Presentation

Jenna Davidner
Barclays Bank PLC, Research Division

Advertisement

All right. I think we’re all set.

Good morning. It’s still morning. Good morning, and welcome to the Barclays Miami Healthcare Conference. My name is Jenna Davidner. I’m one of the analysts here on the Specialty Pharmaceuticals team. And on stage with me, I have Xeris Biopharma. And from the company, we have the CEO, John Shannon. And on the end, we have Steve Pieper, the CFO.

Thank you, guys, for joining, and welcome to the conference.

Advertisement

John Shannon
CEO & Director

Thanks for having us.

Advertisement

Question-and-Answer Session

Jenna Davidner
Barclays Bank PLC, Research Division

So maybe just to level set the conversation, John, can you just give investors that are less familiar a brief overview of the company and your current product portfolio?

Advertisement

John Shannon
CEO & Director

Yes. I’ll just go really high level because I know we’re going to dig into some of this. So Xeris is a — it’s a fast-growing commercial biopharma company. We have 3 commercial products on the market, Gvoke for hypoglycemia. It’s a rescue pen for hypoglycemia, basically an EpiPen for diabetics.

Keveyis. Keveyis is for primary periodic paralysis, which is an ultra-rare hereditary genetic disorder. We can talk a little bit about that asset in a little bit. And then Recorlev. Recorlev is for hypercortisolemia and Cushing’s syndrome, which is our big grower in the business.

On top of that, we have XP-8121, which is our next potential blockbuster, and that’s a once-weekly subcu levothyroxine for hypothyroidism. And that’s Phase III ready. We’re going to get that

Advertisement
Continue Reading

Trending

Copyright © 2025